Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$2.03B |
 |
MedtronicMDT |
-$93M |
 |
Edwards LifesciencesEW |
-$364M |
 |
Intuitive SurgicalISRG |
-$1.36B |
 |
CooperCompaniesCOO |
-$69M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Newcomb George A. | Feb 18, 2025 | Sell | 2,000 | $92.54 | $190,000 |
| Rott Roland | Nov 6, 2024 | Sell | 3,577 | $86.48 | $310,000 |
| Rackliffe Philip | Nov 5, 2024 | Sell | 900 | $87.63 | $79,000 |
| Stacherski Kenneth R. | Aug 14, 2024 | Sell | 19,008 | $83.22 | $1.6M |
| Westrick Thomas J. | Aug 7, 2024 | Sell | 2,750 | $80.78 | $220,000 |
| Kass-Hout Taha | May 28, 2024 | Sell | 3,300 | $78.7 | $260,000 |
| Makela Jan | May 15, 2024 | Sell | 66,955 | $81.54 | $5.5M |
| Makela Jan | May 13, 2024 | Sell | 20,227 | $81.57 | $1.6M |
| Jimenez Frank R | May 1, 2024 | Buy | 1,315 | $76.52 | $100,000 |
FAQ - Insider Transactions
The most recent insider transaction for GE HealthCare was conducted by Newcomb George A., who sold 2,000 shares on February 18, 2025 at a price of $92.54 per share.
Jimenez Frank R has bought the most GEHC stock in the last 2 years, with a total value of $100,000.
Makela Jan has sold the most GEHC stock in the last 2 years, with a total value of $7.1M.
The total value of insider transactions for GE HealthCare in the last 2 years is negative, amounting to -$9.6M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for GE HealthCare have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
